Furthermore, mTOR inhibitors induce Akt activation through an IGF-1R-dependent negative feedback loop in different types of human cancer cell lines, which weakens the anti-tumor effect of mTOR inhibitors [38]. The gene discussed is IGF1R; the disease is cancer.